Palmoplantar pustulosis with psoriatic arthritis ineffective to interleukin-17 inhibitors: two patients successfully treated with upadacitinib
AbstractPalmoplantar pustulosis (PPP) is a rare chronic pustular disease. Psoriatic arthritis (PsA) is one of the common manifestations of arthritis in PPP associated with a high burden of disease. The treatment of PPP is difficult and still in the exploratory stage. Only a few cases show that PPP c...
Saved in:
Main Authors: | Zeng- (Author), Wen-Yao Mi (Author), Yi-Yi Wang (Author), Wei Li (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Upadacitinib for the treatment of psoriatic arthritis
by: Diogo Fonseca, et al.
Published: (2023) -
Pachydermoperiostosis complicated with psoriatic arthritis successfully treated with an anti-interleukin 17A antibody
by: Kyoko Sugioka, MD, et al.
Published: (2023) -
SAPHO Syndrome with Palmoplantar Pustulosis as the First Manifestation Successfully Treated with Adalimumab
by: Yang Q, et al.
Published: (2022) -
Secukinumab-Induced Alopecia Areata Successfully Treated with Tofacitinib in a Patient with Palmoplantar Pustulosis
by: Zhang C, et al.
Published: (2023) -
Successful treatment of refractory tumor necrosis factor inhibitor-induced palmoplantar pustulosis with tofacitinib: Report of case
by: Yixin Ally Wang, BA, et al.
Published: (2020)